LNTH 8-K 2026-11-05

Lantheus Holdings, Inc. (LNTH) 8-K dated 2026-11-05 — accession 0001193125-26-448606.

Lantheus Holdings, Inc. (LNTH) is a drug manufacturers - specialty & generic company listed on US.

Lantheus Holdings, Inc. filed a 8-K on 2026-11-05. Accession 0001193125-26-448606.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported LNTH revenue for 2025-12-31 was $1.54B. Net income was $233.6M. Revenue was up 0.5% from 2024-12-31 to 2025-12-31. LNTH currently screens at market cap $5.56B.

Not investment advice. The LNTH SEC hub lists recent forms. The stock page is the research view.